NGT Healthcare II, an Arieli Capital portfolio company, is a venture capital fund focused exclusively on early-stage life science technologies. The Israeli Innovation Authority has granted NGT a franchise to operate a technological incubator for 5+2 years starting July 2022.
NGT Healthcare II is an impact fund with a vision to propel healthcare and life-saving technologies, encourage Arab society and contribute to a stronger economy and an inclusive and equitable Israeli society.
The fund has already established 10 portfolio companies, and is expected to invest in a total of 20-25 companies during the first 5 years with an additional up to 5 years for follow-on investment and liquidation.
Verticals: Medical Devices, Life Sciences, Biotech
The fund management team has extensive practical experience through the spectrum of product life cycle development. From locating high‐potential technologies, overseeing goal‐directed research and development efforts, to encouraging successive iterations in order to produce innovative products that will be highly valued in the marketplace.
NGT Healthcare II’s know‐how is present in every step of the way, providing a steady experience, guiding the product’s concept hand in hand as it moves and evolves from the early stages of feasibility, preclinical and clinical studies, through to reaching the goal of bringing an innovative new product to the markets that need it.
More about NGT Healthcare: ngt-healthcare2.com.